These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12392774)

  • 1. Brain membrane cholesterol domains, aging and amyloid beta-peptides.
    Wood WG; Schroeder F; Igbavboa U; Avdulov NA; Chochina SV
    Neurobiol Aging; 2002; 23(5):685-94. PubMed ID: 12392774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease.
    Gibson Wood W; Eckert GP; Igbavboa U; Müller WE
    Biochim Biophys Acta; 2003 Mar; 1610(2):281-90. PubMed ID: 12648781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
    Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
    Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol asymmetry in synaptic plasma membranes.
    Wood WG; Igbavboa U; Müller WE; Eckert GP
    J Neurochem; 2011 Mar; 116(5):684-9. PubMed ID: 21214553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.
    Cutler RG; Kelly J; Storie K; Pedersen WA; Tammara A; Hatanpaa K; Troncoso JC; Mattson MP
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2070-5. PubMed ID: 14970312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol, lipids, amyloid Beta, and Alzheimer's.
    Vestergaard M; Hamada T; Morita M; Takagi M
    Curr Alzheimer Res; 2010 May; 7(3):262-70. PubMed ID: 19715550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease.
    Drolle E; Negoda A; Hammond K; Pavlov E; Leonenko Z
    PLoS One; 2017; 12(8):e0182194. PubMed ID: 28767712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
    Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
    Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between amyloid-β peptides and anionic lipid membranes containing cholesterol and melatonin.
    Dies H; Toppozini L; Rheinstädter MC
    PLoS One; 2014; 9(6):e99124. PubMed ID: 24915524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease.
    Drolle E; Hane F; Lee B; Leonenko Z
    Drug Metab Rev; 2014 May; 46(2):207-23. PubMed ID: 24495298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
    Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
    Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal membranes are key to the pathogenesis of Alzheimer's disease: the role of both raft and non-raft membrane domains.
    Williamson R; Sutherland C
    Curr Alzheimer Res; 2011 Mar; 8(2):213-21. PubMed ID: 21222605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embedding Aβ42 in heterogeneous membranes depends on cholesterol asymmetries.
    Liguori N; Nerenberg PS; Head-Gordon T
    Biophys J; 2013 Aug; 105(4):899-910. PubMed ID: 23972842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane injury depends on bilayer lipid composition in Alzheimer's disease.
    Evangelisti E; Zampagni M; Cascella R; Becatti M; Fiorillo C; Caselli A; Bagnoli S; Nacmias B; Cecchi C
    J Alzheimers Dis; 2014; 41(1):289-300. PubMed ID: 24614900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Alzheimer's Abeta(25-35) peptide and phospholipid bilayers: the role of cholesterol.
    D'Errico G; Vitiello G; Ortona O; Tedeschi A; Ramunno A; D'Ursi AM
    Biochim Biophys Acta; 2008 Dec; 1778(12):2710-6. PubMed ID: 18706389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of membrane interaction and aggregation of amyloid β-peptide on lipid mobility and membrane domain structure.
    Sasahara K; Morigaki K; Shinya K
    Phys Chem Chem Phys; 2013 Jun; 15(23):8929-39. PubMed ID: 23515399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of amyloid beta in lipid homeostasis.
    Grösgen S; Grimm MO; Friess P; Hartmann T
    Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.
    Verdier Y; Zarándi M; Penke B
    J Pept Sci; 2004 May; 10(5):229-48. PubMed ID: 15160835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol inhibits the insertion of the Alzheimer's peptide Abeta(25-35) in lipid bilayers.
    Dante S; Hauss T; Dencher NA
    Eur Biophys J; 2006 Aug; 35(6):523-31. PubMed ID: 16670880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.